- Home
- PRLD vs MAXN Comparison
PRLD vs MAXN Comparison
Compare PRLD & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- MAXN
- Stock Information
- Founded
- PRLD 2016
- MAXN 2019
- Country
- PRLD United States
- MAXN Singapore
- Employees
- PRLD N/A
- MAXN N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- MAXN Semiconductors
- Sector
- PRLD Health Care
- MAXN Technology
- Exchange
- PRLD Nasdaq
- MAXN Nasdaq
- Market Cap
- PRLD 69.1M
- MAXN 59.1M
- IPO Year
- PRLD 2020
- MAXN N/A
- Fundamental
- Price
- PRLD $1.42
- MAXN $3.52
- Analyst Decision
- PRLD Strong Buy
- MAXN Sell
- Analyst Count
- PRLD 3
- MAXN 1
- Target Price
- PRLD $4.00
- MAXN $4.00
- AVG Volume (30 Days)
- PRLD 290.5K
- MAXN 108.0K
- Earning Date
- PRLD 11-05-2025
- MAXN 08-14-2025
- Dividend Yield
- PRLD N/A
- MAXN N/A
- EPS Growth
- PRLD N/A
- MAXN N/A
- EPS
- PRLD N/A
- MAXN N/A
- Revenue
- PRLD $7,000,000.00
- MAXN $176,414,000.00
- Revenue This Year
- PRLD N/A
- MAXN $100.37
- Revenue Next Year
- PRLD N/A
- MAXN $24.61
- P/E Ratio
- PRLD N/A
- MAXN N/A
- Revenue Growth
- PRLD N/A
- MAXN N/A
- 52 Week Low
- PRLD $0.61
- MAXN $2.49
- 52 Week High
- PRLD $2.08
- MAXN $14.49
- Technical
- Relative Strength Index (RSI)
- PRLD 60.29
- MAXN 43.50
- Support Level
- PRLD $1.33
- MAXN $3.36
- Resistance Level
- PRLD $1.63
- MAXN $3.85
- Average True Range (ATR)
- PRLD 0.18
- MAXN 0.22
- MACD
- PRLD 0.01
- MAXN -0.01
- Stochastic Oscillator
- PRLD 49.42
- MAXN 40.50
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.